Lobbying

Mallinckrodt's latest lobbying report covers Q3 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Mallinckrodt

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Mallinckrodt lobbying by quarter
Mallinckrodt lobbying by quarter
QuarterAmountReports
Q4 2022$100K2
Q1 2023$40K1
Q2 2023$50K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$01
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$203.3K · 12 reports
  • Medicare and Medicaid$203.3K · 12 reports
  • Taxation$163.3K · 10 reports
  • Pharmacy$20K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES12 reports
  • SENATE12 reports

Firms it paid

Firm
Alpine Group Partners$530K12 quarters
Oxford Strategies$60K1 quarters

Former officials lobbying for it

Former position
KEENAN AUSTIN REEDChief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. WilsonQ2 2025

Lobbying reports

Filed by
25/10/20for Q3 2025Alpine Group PartnersUnder $5,000
25/07/19for Q2 2025Alpine Group Partners$50K
25/04/21for Q1 2025Alpine Group Partners$50K
25/01/21for Q4 2024Alpine Group Partners$50K
24/10/21for Q3 2024Alpine Group Partners$50K
24/07/23for Q2 2024Alpine Group Partners$50K
24/04/21for Q1 2024Alpine Group Partners$50K
24/01/22for Q4 2023Alpine Group Partners$50K
23/10/19for Q3 2023Alpine Group Partners$50K
23/07/18for Q2 2023Alpine Group Partners$50K
23/04/20for Q1 2023Alpine Group Partners$40K
23/01/20for Q4 2022Alpine Group Partners$40K
23/01/20for Q4 2022Oxford Strategies$60K